Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

520

Participants

Timeline

Start Date

November 11, 2016

Primary Completion Date

October 11, 2024

Study Completion Date

October 11, 2024

Conditions
Mesothelioma
Interventions
DRUG

Cisplatin

DRUG

Pemetrexed

DRUG

Pembrolizumab

Trial Locations (57)

13915

Marseille - Hopital Nord, Marseille

14000

Caen - CHU, Caen

15121

Oncologia SS Antonio e Biagio Alessandria, Alessandria

16149

U.O. di Oncologia Ospedale Villa Scassi, Genova

20089

Instituto Clinico Humanitas, Rozzano (MI)

20133

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

24125

Oncologia Medica Humanitas Gavazzeni Bergamo, Bergamo

25030

Hopital Jean Minjoz, Besançon

29100

Azienda USL di Piacenza, Ospedale Gugliemimo Salieto, Piacenza

30035

U.O.C. di Oncologia U.L.S.S. 13, Mirano

31059

Hopital Larrey, Toulouse

33076

Institut Bergonie, Bordeaux

35033

CHU Rennes - Hopital Pontchaillou, Rennes

37044

CHRU de Tours - Hopital Bretonneau, Tours

42123

Oncologia Medica IRCCS Arcispedale Maria, Reggio Emilia

44805

Centre Rene Gauducheau, Nantes

47014

Intstituto Scientifico Romangnolo, Meldola

49033

CHU - Angers, Angers

54500

Centre Alexis Vautrin, Vandœuvre-lès-Nancy

56100

Hopital du Scorff, Lorient

59037

Lille - Hopital Calmette, Lille

63003

Clermont-Ferrand - CHU, Clermont-Ferrand

67091

Nouvel Hopital Civil Hopitaux, Strasbourg

68070

Centre Hospitalier de Mulhouse, Mulhouse

69310

Lyon URCOT, Pierre-Bénite

70124

IRCCS Ospedale Oncologico Giovanni Paolo II, Bari

72037

Centre Hospitalier du Mans, Le Mans

72100

PO A Perrino ASL Brindisi - UOC Oncologia Medica, Brindisi

75877

Hopital Bichat, Paris

75970

AP-HP Hopital Tenon, Paris

80131

Azienda Ospedaliera di Rilievo Nazionale, Napoli

Dott. Fortunato Ciardiello,Cattedra Oncologia Medica, Napoli

U.O.S.D. Day Hospital Oncologico-Pneumologico, Napoli

Unita Sperimentazioni Cliniche Istituto per lo, Napoli

83056

CHITS Toulon Sainte Musse, Toulon

83100

Azienda Ospedaliera San Giuseppe Moscati, Avellino

87042

CHU Dupuytren, Limoges

92104

Boulogne - Ambroise Pare, Boulogne

94000

Centre Hospitalier Intercommunal de Creteil, Créteil

94805

Institut Gustave-Roussy, Villejuif

95123

Azienda Ospedaliera Garibaldi Nesima, Catania

95125

AOU Policlinico Vittorio Emanuele UOC di Oncologia, Catania

T2N 4N2

Tom Baker Cancer Centre, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

V1Y 5L3

BCCA - Cancer Centre for the Southern Interior, Kelowna

V3V 1Z2

BCCA - Fraser Valley Cancer Centre, Surrey

R3E 0V9

CancerCare Manitoba, Winnipeg

L8V 5C2

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton

N6A 5W9

London Regional Cancer Program, London

K1H 8L6

Ottawa Hospital Research Institute, Ottawa

M5G 2M9

University Health Network, Toronto

H2X 3E4

CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal

H4A 3J1

The Research Institute of the McGill University, Montreal

G1V 4G5

University Institute of Cardiology and, Québec

S4T 7T1

Allan Blair Cancer Centre, Regina

CEDEX 5

Montpellier

00144

Istituti Fisioterapici Ospitalieri IFO Istituto, Rome

All Listed Sponsors
collaborator

National Cancer Institute, Naples

OTHER

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Intergroupe Francophone de Cancerologie Thoracique

OTHER

lead

Canadian Cancer Trials Group

NETWORK

NCT02784171 - Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma | Biotech Hunter | Biotech Hunter